

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.28277902 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.04457935 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.80336468 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.66679102 |
| 5 | vocalization behavior (GO:0071625) | 5.58422779 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.55734515 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.52925850 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.24207466 |
| 9 | glutamate secretion (GO:0014047) | 5.19037615 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10306346 |
| 11 | protein localization to synapse (GO:0035418) | 5.00097909 |
| 12 | exploration behavior (GO:0035640) | 4.85439577 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.79990908 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.77600569 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.74629373 |
| 16 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.65675461 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.62670323 |
| 18 | dendritic spine morphogenesis (GO:0060997) | 4.56455655 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.55040823 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 4.52507675 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.35667728 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.30417072 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 4.27672762 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.24703517 |
| 25 | neurotransmitter secretion (GO:0007269) | 4.22484244 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.15348307 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.09395456 |
| 28 | positive regulation of synapse maturation (GO:0090129) | 3.99535090 |
| 29 | neuronal action potential propagation (GO:0019227) | 3.99533459 |
| 30 | neuron recognition (GO:0008038) | 3.98920774 |
| 31 | proline transport (GO:0015824) | 3.93557142 |
| 32 | long-term memory (GO:0007616) | 3.89495779 |
| 33 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.87224687 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 3.86898560 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.85154121 |
| 36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.83959164 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.83944602 |
| 38 | cellular potassium ion homeostasis (GO:0030007) | 3.72514712 |
| 39 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.71737379 |
| 40 | axonal fasciculation (GO:0007413) | 3.69547392 |
| 41 | postsynaptic membrane organization (GO:0001941) | 3.67721395 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.64773831 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.63721891 |
| 44 | regulation of ARF protein signal transduction (GO:0032012) | 3.55665605 |
| 45 | dendrite morphogenesis (GO:0048813) | 3.52928913 |
| 46 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.48171064 |
| 47 | transmission of nerve impulse (GO:0019226) | 3.47178478 |
| 48 | sodium ion export (GO:0071436) | 3.44539535 |
| 49 | dendritic spine organization (GO:0097061) | 3.44262483 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.41990019 |
| 51 | neurotransmitter transport (GO:0006836) | 3.40420157 |
| 52 | synaptic vesicle endocytosis (GO:0048488) | 3.40314435 |
| 53 | cell communication by electrical coupling (GO:0010644) | 3.38852174 |
| 54 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.38401993 |
| 55 | positive regulation of dendritic spine development (GO:0060999) | 3.38339018 |
| 56 | neuromuscular process controlling balance (GO:0050885) | 3.37513909 |
| 57 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.37197866 |
| 58 | auditory behavior (GO:0031223) | 3.37066705 |
| 59 | innervation (GO:0060384) | 3.36631941 |
| 60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.36004970 |
| 61 | regulation of vesicle fusion (GO:0031338) | 3.35075546 |
| 62 | long-term synaptic potentiation (GO:0060291) | 3.33696478 |
| 63 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.32911378 |
| 64 | establishment of mitochondrion localization (GO:0051654) | 3.32319563 |
| 65 | activation of protein kinase A activity (GO:0034199) | 3.31532169 |
| 66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31404103 |
| 67 | regulation of neurotransmitter secretion (GO:0046928) | 3.28254329 |
| 68 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.27633279 |
| 69 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.26516584 |
| 70 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.25443777 |
| 71 | behavioral defense response (GO:0002209) | 3.20206798 |
| 72 | behavioral fear response (GO:0001662) | 3.20206798 |
| 73 | response to auditory stimulus (GO:0010996) | 3.17706114 |
| 74 | regulation of dendritic spine development (GO:0060998) | 3.17485076 |
| 75 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.17444587 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 3.16524707 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.13630174 |
| 78 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.13380061 |
| 79 | cell migration in hindbrain (GO:0021535) | 3.13100850 |
| 80 | presynaptic membrane assembly (GO:0097105) | 3.12487630 |
| 81 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.12227565 |
| 82 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.11089996 |
| 83 | cerebellar Purkinje cell layer development (GO:0021680) | 3.09646636 |
| 84 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.09477553 |
| 85 | membrane depolarization (GO:0051899) | 3.08386580 |
| 86 | learning (GO:0007612) | 3.07340803 |
| 87 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.05667170 |
| 88 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04290369 |
| 89 | regulation of synapse maturation (GO:0090128) | 3.02525991 |
| 90 | fear response (GO:0042596) | 3.02361582 |
| 91 | synapse assembly (GO:0007416) | 3.00182579 |
| 92 | regulation of synaptic transmission (GO:0050804) | 2.98727019 |
| 93 | regulation of neurotransmitter transport (GO:0051588) | 2.98337097 |
| 94 | neuronal ion channel clustering (GO:0045161) | 2.98096383 |
| 95 | vesicle transport along microtubule (GO:0047496) | 2.94804062 |
| 96 | social behavior (GO:0035176) | 2.94011190 |
| 97 | intraspecies interaction between organisms (GO:0051703) | 2.94011190 |
| 98 | neuromuscular process controlling posture (GO:0050884) | 2.92637668 |
| 99 | membrane hyperpolarization (GO:0060081) | 2.91689132 |
| 100 | positive regulation of synaptic transmission (GO:0050806) | 2.91007864 |
| 101 | presynaptic membrane organization (GO:0097090) | 2.89274800 |
| 102 | response to pheromone (GO:0019236) | 2.89194317 |
| 103 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88903948 |
| 104 | negative regulation of cell killing (GO:0031342) | 2.88903948 |
| 105 | cerebellar granule cell differentiation (GO:0021707) | 2.88834419 |
| 106 | membrane depolarization during action potential (GO:0086010) | 2.88639422 |
| 107 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.88329826 |
| 108 | protein localization to endosome (GO:0036010) | 2.81942800 |
| 109 | mitochondrion transport along microtubule (GO:0047497) | 2.78899364 |
| 110 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.78899364 |
| 111 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.78297953 |
| 112 | positive regulation by symbiont of host defense response (GO:0052509) | 2.75681730 |
| 113 | modulation by symbiont of host defense response (GO:0052031) | 2.75681730 |
| 114 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.75681730 |
| 115 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.75681730 |
| 116 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.75681730 |
| 117 | modulation by symbiont of host immune response (GO:0052553) | 2.75681730 |
| 118 | cellular response to catecholamine stimulus (GO:0071870) | 2.68469477 |
| 119 | cellular response to monoamine stimulus (GO:0071868) | 2.68469477 |
| 120 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.63397777 |
| 121 | regulation of ARF GTPase activity (GO:0032312) | 2.62848657 |
| 122 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.61550119 |
| 123 | cell-cell junction maintenance (GO:0045217) | 2.61191502 |
| 124 | regulation of regulated secretory pathway (GO:1903305) | 2.56530969 |
| 125 | amino acid import (GO:0043090) | 2.54466474 |
| 126 | positive regulation of protein dephosphorylation (GO:0035307) | 2.48737180 |
| 127 | negative regulation of microtubule polymerization (GO:0031115) | 2.46964463 |
| 128 | axon extension (GO:0048675) | 2.46263088 |
| 129 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.43487831 |
| 130 | nucleobase catabolic process (GO:0046113) | 2.40639534 |
| 131 | signal complex assembly (GO:0007172) | 2.39779310 |
| 132 | neuron projection extension (GO:1990138) | 2.38435168 |
| 133 | macrophage activation involved in immune response (GO:0002281) | 2.36080643 |
| 134 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.34887311 |
| 135 | L-amino acid import (GO:0043092) | 2.32603524 |
| 136 | protein retention in ER lumen (GO:0006621) | 2.31991656 |
| 137 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.31443120 |
| 138 | positive regulation of fibroblast migration (GO:0010763) | 2.30620415 |
| 139 | dopamine receptor signaling pathway (GO:0007212) | 2.29292572 |
| 140 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.29214852 |
| 141 | response to parathyroid hormone (GO:0071107) | 2.26933550 |
| 142 | organelle transport along microtubule (GO:0072384) | 2.26735400 |
| 143 | positive regulation of synapse assembly (GO:0051965) | 2.26405479 |
| 144 | protein targeting to plasma membrane (GO:0072661) | 2.25898227 |
| 145 | positive regulation of neurotransmitter transport (GO:0051590) | 2.25706595 |
| 146 | positive regulation of axon extension (GO:0045773) | 2.25110637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.22811402 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.62766112 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.28405693 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.20933346 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.17600519 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.11797525 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.84346538 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.84346538 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.82097676 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.81615722 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.69294893 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69099526 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.67536417 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.63937715 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.61205773 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.60972036 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.57713201 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54874573 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.52561396 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.44600315 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.41580452 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.41537045 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40222446 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.33683722 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.33276434 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.30007449 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.23285440 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.22150299 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.12923236 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.04850267 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.01181806 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.00755035 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.99716644 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89671137 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84049578 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78936309 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78173868 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73104209 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71634783 |
| 40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.68632124 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.68504160 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68120452 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59598474 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59014671 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58411647 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56093594 |
| 47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.52927774 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51891340 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51118769 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48923160 |
| 51 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.45555002 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45356945 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44834522 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.44082763 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42381650 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37135656 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36785345 |
| 58 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35893681 |
| 59 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35479335 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35166406 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34973407 |
| 62 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32857345 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32835252 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32363872 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32189650 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28912125 |
| 67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27556583 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27396708 |
| 69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26607081 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25466430 |
| 71 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25118895 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24995090 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24531280 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24285553 |
| 75 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.23627888 |
| 76 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23124004 |
| 77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22150382 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.20652503 |
| 79 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20006888 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19166420 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18283387 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 1.18269283 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17553530 |
| 84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17252827 |
| 85 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16827002 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16549319 |
| 87 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15956251 |
| 88 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.15367987 |
| 89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14017996 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13943524 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12546214 |
| 92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10566908 |
| 93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09576803 |
| 94 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09448555 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09162169 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08646661 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08208669 |
| 98 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07262844 |
| 99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06567881 |
| 100 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06468516 |
| 101 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05574651 |
| 102 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04811545 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04747978 |
| 104 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04115598 |
| 105 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03194740 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02505456 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01711760 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01348737 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01041156 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00893577 |
| 111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00875638 |
| 112 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00038178 |
| 113 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99761993 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99329149 |
| 115 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99201828 |
| 116 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.98533294 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98123971 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98081848 |
| 119 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97535889 |
| 120 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96389666 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95985909 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95747374 |
| 123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95603774 |
| 124 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95015873 |
| 125 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94946356 |
| 126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94677908 |
| 127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94316353 |
| 128 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94084522 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94039340 |
| 130 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93818073 |
| 131 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.93559494 |
| 132 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93091682 |
| 133 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.92925616 |
| 134 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92472163 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92006582 |
| 136 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91989861 |
| 137 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91786831 |
| 138 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91386229 |
| 139 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91233493 |
| 140 | SA1_27219007_Chip-Seq_Bcells_Human | 0.90591443 |
| 141 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90025872 |
| 142 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90004239 |
| 143 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89868935 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89526626 |
| 145 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88575490 |
| 146 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88512960 |
| 147 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87887356 |
| 148 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87426661 |
| 149 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86220469 |
| 150 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85906405 |
| 151 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85049213 |
| 152 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84723063 |
| 153 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82489682 |
| 154 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.82489682 |
| 155 | JUN_21703547_ChIP-Seq_K562_Human | 0.81713304 |
| 156 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81669609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.06374635 |
| 2 | MP0003880_abnormal_central_pattern | 4.82323368 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.26642042 |
| 4 | MP0004270_analgesia | 3.76727870 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.45774429 |
| 6 | MP0009745_abnormal_behavioral_response | 3.41453094 |
| 7 | MP0002064_seizures | 3.07773023 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.92847268 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.84047576 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.80344708 |
| 11 | MP0009046_muscle_twitch | 2.63216205 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.57747736 |
| 13 | MP0002822_catalepsy | 2.50915347 |
| 14 | MP0001486_abnormal_startle_reflex | 2.45678504 |
| 15 | MP0002272_abnormal_nervous_system | 2.42111355 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.32121525 |
| 17 | MP0002736_abnormal_nociception_after | 2.22224040 |
| 18 | MP0003329_amyloid_beta_deposits | 2.22180701 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.21229384 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.15413788 |
| 21 | MP0000778_abnormal_nervous_system | 2.14985925 |
| 22 | MP0008260_abnormal_autophagy | 2.12059632 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.11649582 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.10115116 |
| 25 | MP0004858_abnormal_nervous_system | 2.05804089 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.05478153 |
| 27 | MP0002184_abnormal_innervation | 1.93757218 |
| 28 | MP0001970_abnormal_pain_threshold | 1.90147471 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.85284427 |
| 30 | MP0003724_increased_susceptibility_to | 1.85137483 |
| 31 | MP0001958_emphysema | 1.83902997 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.83278525 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.79253177 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.76368125 |
| 35 | MP0003436_decreased_susceptibility_to | 1.75215649 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.74509135 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.73490844 |
| 38 | MP0008569_lethality_at_weaning | 1.71169159 |
| 39 | MP0000955_abnormal_spinal_cord | 1.67314842 |
| 40 | MP0003303_peritoneal_inflammation | 1.66144342 |
| 41 | MP0004924_abnormal_behavior | 1.64299334 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.64299334 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.52751937 |
| 44 | MP0001984_abnormal_olfaction | 1.51941655 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.49631050 |
| 46 | MP0003879_abnormal_hair_cell | 1.49478428 |
| 47 | MP0004885_abnormal_endolymph | 1.49459719 |
| 48 | MP0001529_abnormal_vocalization | 1.43782510 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.41772598 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.36393860 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.36248884 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.34027331 |
| 53 | MP0001905_abnormal_dopamine_level | 1.31109131 |
| 54 | MP0003123_paternal_imprinting | 1.29879949 |
| 55 | MP0003787_abnormal_imprinting | 1.29158285 |
| 56 | MP0003122_maternal_imprinting | 1.27926752 |
| 57 | MP0003279_aneurysm | 1.24724060 |
| 58 | MP0003633_abnormal_nervous_system | 1.22403150 |
| 59 | MP0002152_abnormal_brain_morphology | 1.21777120 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.17563046 |
| 61 | MP0004142_abnormal_muscle_tone | 1.12984759 |
| 62 | MP0000750_abnormal_muscle_regeneration | 1.12947293 |
| 63 | MP0002653_abnormal_ependyma_morphology | 1.11622954 |
| 64 | MP0003631_nervous_system_phenotype | 1.08656898 |
| 65 | MP0000604_amyloidosis | 1.01551488 |
| 66 | MP0001542_abnormal_bone_strength | 1.01532543 |
| 67 | MP0000751_myopathy | 1.00743093 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 1.00394492 |
| 69 | MP0001533_abnormal_skeleton_physiology | 0.99629255 |
| 70 | MP0001348_abnormal_lacrimal_gland | 0.99354126 |
| 71 | MP0003283_abnormal_digestive_organ | 0.98621079 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.98429130 |
| 73 | MP0005409_darkened_coat_color | 0.95144882 |
| 74 | MP0010386_abnormal_urinary_bladder | 0.94225487 |
| 75 | MP0003300_gastrointestinal_ulcer | 0.92301942 |
| 76 | MP0003634_abnormal_glial_cell | 0.91107373 |
| 77 | MP0002229_neurodegeneration | 0.90653645 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.90307964 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.88953732 |
| 80 | MP0002249_abnormal_larynx_morphology | 0.88251480 |
| 81 | MP0003075_altered_response_to | 0.87387229 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.87238639 |
| 83 | MP0005499_abnormal_olfactory_system | 0.86741313 |
| 84 | MP0005394_taste/olfaction_phenotype | 0.86741313 |
| 85 | MP0009278_abnormal_bone_marrow | 0.86270021 |
| 86 | MP0003632_abnormal_nervous_system | 0.85559653 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.85372165 |
| 88 | MP0001177_atelectasis | 0.85333111 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.84940651 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.84615365 |
| 91 | MP0004130_abnormal_muscle_cell | 0.84053563 |
| 92 | MP0008872_abnormal_physiological_respon | 0.82979513 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.81806183 |
| 94 | MP0002419_abnormal_innate_immunity | 0.81645779 |
| 95 | MP0001188_hyperpigmentation | 0.81144472 |
| 96 | MP0004085_abnormal_heartbeat | 0.80566847 |
| 97 | MP0000569_abnormal_digit_pigmentation | 0.80538137 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.80358019 |
| 99 | MP0000747_muscle_weakness | 0.78969399 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.78799989 |
| 101 | MP0004742_abnormal_vestibular_system | 0.78586516 |
| 102 | MP0005535_abnormal_body_temperature | 0.77101959 |
| 103 | MP0001963_abnormal_hearing_physiology | 0.76450516 |
| 104 | MP0003091_abnormal_cell_migration | 0.76260862 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.75630862 |
| 106 | MP0008874_decreased_physiological_sensi | 0.75475280 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.73555502 |
| 108 | MP0002090_abnormal_vision | 0.73341472 |
| 109 | MP0005248_abnormal_Harderian_gland | 0.73099959 |
| 110 | MP0003861_abnormal_nervous_system | 0.72938836 |
| 111 | MP0000920_abnormal_myelination | 0.71626320 |
| 112 | MP0003690_abnormal_glial_cell | 0.70370002 |
| 113 | MP0005451_abnormal_body_composition | 0.69520666 |
| 114 | MP0005390_skeleton_phenotype | 0.68338543 |
| 115 | MP0000534_abnormal_ureter_morphology | 0.67011181 |
| 116 | MP0003121_genomic_imprinting | 0.65974159 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.65707315 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.65628534 |
| 119 | MP0005623_abnormal_meninges_morphology | 0.65537731 |
| 120 | MP0005503_abnormal_tendon_morphology | 0.64685360 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.64577064 |
| 122 | MP0005187_abnormal_penis_morphology | 0.63110664 |
| 123 | MP0002638_abnormal_pupillary_reflex | 0.63069265 |
| 124 | MP0005166_decreased_susceptibility_to | 0.62516083 |
| 125 | MP0004233_abnormal_muscle_weight | 0.61739383 |
| 126 | MP0001664_abnormal_digestion | 0.61651439 |
| 127 | MP0004215_abnormal_myocardial_fiber | 0.60314539 |
| 128 | MP0004510_myositis | 0.58729296 |
| 129 | MP0009840_abnormal_foam_cell | 0.58621583 |
| 130 | MP0003172_abnormal_lysosome_physiology | 0.57874108 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.56432553 |
| 132 | MP0001943_abnormal_respiration | 0.55271590 |
| 133 | MP0006072_abnormal_retinal_apoptosis | 0.54427139 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.54007905 |
| 135 | MP0004484_altered_response_of | 0.53729394 |
| 136 | MP0010769_abnormal_survival | 0.53704405 |
| 137 | MP0001485_abnormal_pinna_reflex | 0.51579294 |
| 138 | MP0010770_preweaning_lethality | 0.51518521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.03454677 |
| 2 | Myokymia (HP:0002411) | 6.95184334 |
| 3 | Visual hallucinations (HP:0002367) | 5.55580670 |
| 4 | Focal seizures (HP:0007359) | 5.49669840 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.60825921 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.26392423 |
| 7 | Atonic seizures (HP:0010819) | 4.05147871 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 4.00831002 |
| 9 | Absence seizures (HP:0002121) | 3.82888823 |
| 10 | Febrile seizures (HP:0002373) | 3.81357103 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.68012867 |
| 12 | Action tremor (HP:0002345) | 3.63853269 |
| 13 | Ankle clonus (HP:0011448) | 3.56597018 |
| 14 | Dialeptic seizures (HP:0011146) | 3.52446980 |
| 15 | Mutism (HP:0002300) | 3.44218598 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.35125766 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.29279632 |
| 18 | Broad-based gait (HP:0002136) | 3.28199520 |
| 19 | Poor eye contact (HP:0000817) | 3.26980383 |
| 20 | Depression (HP:0000716) | 3.25657301 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.24808728 |
| 22 | Abnormality of the lower motor neuron (HP:0002366) | 3.20602612 |
| 23 | Amblyopia (HP:0000646) | 3.06242155 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.04180267 |
| 25 | Dysdiadochokinesis (HP:0002075) | 3.02925216 |
| 26 | Anxiety (HP:0000739) | 3.01793880 |
| 27 | Dysmetria (HP:0001310) | 2.98900865 |
| 28 | Peritonitis (HP:0002586) | 2.98384793 |
| 29 | Genetic anticipation (HP:0003743) | 2.96589674 |
| 30 | Impaired social interactions (HP:0000735) | 2.94981821 |
| 31 | Abnormal social behavior (HP:0012433) | 2.94981821 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.94760496 |
| 33 | Truncal ataxia (HP:0002078) | 2.92966821 |
| 34 | Hemiparesis (HP:0001269) | 2.91959548 |
| 35 | Papilledema (HP:0001085) | 2.90199292 |
| 36 | Drooling (HP:0002307) | 2.88698108 |
| 37 | Excessive salivation (HP:0003781) | 2.88698108 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.87137129 |
| 39 | Hyperventilation (HP:0002883) | 2.85389094 |
| 40 | Torticollis (HP:0000473) | 2.83370594 |
| 41 | Postural instability (HP:0002172) | 2.80340727 |
| 42 | Abnormality of binocular vision (HP:0011514) | 2.69164267 |
| 43 | Diplopia (HP:0000651) | 2.69164267 |
| 44 | Urinary urgency (HP:0000012) | 2.68555243 |
| 45 | Spastic gait (HP:0002064) | 2.68382080 |
| 46 | Focal dystonia (HP:0004373) | 2.67889758 |
| 47 | Epileptiform EEG discharges (HP:0011182) | 2.67457409 |
| 48 | Abnormality of the corticospinal tract (HP:0002492) | 2.66155222 |
| 49 | Hand muscle atrophy (HP:0009130) | 2.62442833 |
| 50 | Protrusio acetabuli (HP:0003179) | 2.60226919 |
| 51 | Premature rupture of membranes (HP:0001788) | 2.60173607 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 2.59317140 |
| 53 | Upper limb amyotrophy (HP:0009129) | 2.59317140 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.57529997 |
| 55 | Peripheral hypomyelination (HP:0007182) | 2.54166523 |
| 56 | Amyotrophic lateral sclerosis (HP:0007354) | 2.53664362 |
| 57 | Megalencephaly (HP:0001355) | 2.52695534 |
| 58 | Impaired smooth pursuit (HP:0007772) | 2.49906680 |
| 59 | Limb dystonia (HP:0002451) | 2.48662905 |
| 60 | Hemiplegia (HP:0002301) | 2.47842739 |
| 61 | Hypsarrhythmia (HP:0002521) | 2.46612651 |
| 62 | Scanning speech (HP:0002168) | 2.44878950 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.44163327 |
| 64 | Termporal pattern (HP:0011008) | 2.44143151 |
| 65 | Insidious onset (HP:0003587) | 2.44143151 |
| 66 | Stereotypic behavior (HP:0000733) | 2.43722333 |
| 67 | Slender build (HP:0001533) | 2.42726014 |
| 68 | Polyphagia (HP:0002591) | 2.41930327 |
| 69 | Bradykinesia (HP:0002067) | 2.39709339 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.39521665 |
| 71 | Insomnia (HP:0100785) | 2.38555234 |
| 72 | Genu recurvatum (HP:0002816) | 2.37405808 |
| 73 | Craniofacial dystonia (HP:0012179) | 2.36639461 |
| 74 | Intention tremor (HP:0002080) | 2.35614762 |
| 75 | Progressive inability to walk (HP:0002505) | 2.34551382 |
| 76 | Lower limb muscle weakness (HP:0007340) | 2.29694583 |
| 77 | Agitation (HP:0000713) | 2.26553794 |
| 78 | Amyloidosis (HP:0011034) | 2.23301760 |
| 79 | Fetal akinesia sequence (HP:0001989) | 2.22338327 |
| 80 | Absent speech (HP:0001344) | 2.22270371 |
| 81 | Cerebral aneurysm (HP:0004944) | 2.21261819 |
| 82 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.18789018 |
| 83 | Myositis (HP:0100614) | 2.16709154 |
| 84 | Impaired vibratory sensation (HP:0002495) | 2.16108834 |
| 85 | Generalized myoclonic seizures (HP:0002123) | 2.12421717 |
| 86 | Akinesia (HP:0002304) | 2.11496750 |
| 87 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11359533 |
| 88 | Orchitis (HP:0100796) | 2.10550802 |
| 89 | Obstructive sleep apnea (HP:0002870) | 2.09107869 |
| 90 | Abnormality of macrophages (HP:0004311) | 2.08685086 |
| 91 | Ventricular fibrillation (HP:0001663) | 2.08643362 |
| 92 | Apathy (HP:0000741) | 2.06043441 |
| 93 | Pointed chin (HP:0000307) | 2.05943583 |
| 94 | Episodic fever (HP:0001954) | 2.05859026 |
| 95 | Hyperacusis (HP:0010780) | 2.01814203 |
| 96 | Difficulty climbing stairs (HP:0003551) | 2.00919569 |
| 97 | Delusions (HP:0000746) | 2.00568613 |
| 98 | Shallow orbits (HP:0000586) | 2.00140529 |
| 99 | Status epilepticus (HP:0002133) | 1.98237323 |
| 100 | Hypercortisolism (HP:0001578) | 1.97025301 |
| 101 | Inability to walk (HP:0002540) | 1.96096960 |
| 102 | Hypochromic microcytic anemia (HP:0004840) | 1.95296428 |
| 103 | Pheochromocytoma (HP:0002666) | 1.92546221 |
| 104 | Incomplete penetrance (HP:0003829) | 1.92303068 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.91443758 |
| 106 | Clonus (HP:0002169) | 1.91399522 |
| 107 | Mitral regurgitation (HP:0001653) | 1.89244478 |
| 108 | Long palpebral fissure (HP:0000637) | 1.88716588 |
| 109 | Rapidly progressive (HP:0003678) | 1.88154067 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87841089 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87841089 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87841089 |
| 113 | Lower limb amyotrophy (HP:0007210) | 1.87831511 |
| 114 | Abnormality of salivation (HP:0100755) | 1.87274595 |
| 115 | Annular pancreas (HP:0001734) | 1.86311967 |
| 116 | Dysmetric saccades (HP:0000641) | 1.85817684 |
| 117 | Spinal canal stenosis (HP:0003416) | 1.85374341 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 1.85320648 |
| 119 | Nuclear cataract (HP:0100018) | 1.85020734 |
| 120 | Gait ataxia (HP:0002066) | 1.83135578 |
| 121 | Inappropriate behavior (HP:0000719) | 1.81910390 |
| 122 | Recurrent abscess formation (HP:0002722) | 1.81807123 |
| 123 | Decreased motor nerve conduction velocity (HP:0003431) | 1.81667303 |
| 124 | Growth hormone excess (HP:0000845) | 1.81376417 |
| 125 | Hypoventilation (HP:0002791) | 1.81363707 |
| 126 | Diminished motivation (HP:0000745) | 1.80039962 |
| 127 | Increased connective tissue (HP:0009025) | 1.77780045 |
| 128 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.76139247 |
| 129 | Hypoplasia of the brainstem (HP:0002365) | 1.76017151 |
| 130 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.76017151 |
| 131 | Broad metatarsal (HP:0001783) | 1.75994225 |
| 132 | Anosmia (HP:0000458) | 1.75852283 |
| 133 | Psychosis (HP:0000709) | 1.74375291 |
| 134 | Sleep apnea (HP:0010535) | 1.73471194 |
| 135 | Rigidity (HP:0002063) | 1.73139494 |
| 136 | Retinal dysplasia (HP:0007973) | 1.70738940 |
| 137 | Dilatation of the ascending aorta (HP:0005111) | 1.70564542 |
| 138 | Broad face (HP:0000283) | 1.70155560 |
| 139 | Bladder diverticulum (HP:0000015) | 1.70111567 |
| 140 | Thin bony cortex (HP:0002753) | 1.69367011 |
| 141 | Wrist flexion contracture (HP:0001239) | 1.68746740 |
| 142 | Distal lower limb amyotrophy (HP:0008944) | 1.68399279 |
| 143 | Cholecystitis (HP:0001082) | 1.68361375 |
| 144 | Abnormal gallbladder physiology (HP:0012438) | 1.68361375 |
| 145 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.67626638 |
| 146 | Mucopolysacchariduria (HP:0008155) | 1.67626638 |
| 147 | Ankle contracture (HP:0006466) | 1.67412971 |
| 148 | Dysostosis multiplex (HP:0000943) | 1.66912883 |
| 149 | Hyperextensible skin (HP:0000974) | 1.64419120 |
| 150 | Vertebral compression fractures (HP:0002953) | 1.64137680 |
| 151 | Gastrointestinal infarctions (HP:0005244) | 1.63684870 |
| 152 | Stridor (HP:0010307) | 1.61733024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.48633273 |
| 2 | EPHA4 | 4.31087173 |
| 3 | MAP3K9 | 4.08352133 |
| 4 | MARK1 | 3.96800242 |
| 5 | MINK1 | 2.83328936 |
| 6 | MAP3K4 | 2.64584758 |
| 7 | TRIB3 | 2.53157995 |
| 8 | EPHB1 | 2.41645384 |
| 9 | DAPK2 | 2.39691365 |
| 10 | PAK6 | 2.37024874 |
| 11 | ERN1 | 2.22166618 |
| 12 | MAP2K7 | 2.19420633 |
| 13 | NTRK2 | 2.17970133 |
| 14 | KSR2 | 2.15887123 |
| 15 | PRKD3 | 2.08482642 |
| 16 | KSR1 | 1.97521532 |
| 17 | TESK1 | 1.92000462 |
| 18 | TNK2 | 1.80768256 |
| 19 | MAP3K11 | 1.78532200 |
| 20 | NTRK1 | 1.76707668 |
| 21 | SIK1 | 1.74905609 |
| 22 | CAMKK1 | 1.74782560 |
| 23 | PRKD2 | 1.70011787 |
| 24 | MAP2K4 | 1.60385867 |
| 25 | CDK5 | 1.60188935 |
| 26 | TNIK | 1.56176569 |
| 27 | MAP3K12 | 1.51352493 |
| 28 | ARAF | 1.51260930 |
| 29 | PRPF4B | 1.49086607 |
| 30 | SIK2 | 1.45839539 |
| 31 | MAPK13 | 1.45824046 |
| 32 | PLK2 | 1.44984345 |
| 33 | DAPK1 | 1.43835163 |
| 34 | RIPK4 | 1.42773021 |
| 35 | MAP2K3 | 1.39264598 |
| 36 | LATS2 | 1.34907813 |
| 37 | GRK5 | 1.33609935 |
| 38 | IRAK4 | 1.33439088 |
| 39 | CASK | 1.32439014 |
| 40 | PNCK | 1.29110340 |
| 41 | UHMK1 | 1.28650468 |
| 42 | PRKCG | 1.24787616 |
| 43 | PHKG2 | 1.23344418 |
| 44 | PHKG1 | 1.23344418 |
| 45 | STK38 | 1.19416685 |
| 46 | TYRO3 | 1.19026597 |
| 47 | TESK2 | 1.13646673 |
| 48 | MAP3K13 | 1.10340868 |
| 49 | MAP3K2 | 1.09727225 |
| 50 | FES | 1.09413507 |
| 51 | CDK19 | 1.08463868 |
| 52 | LIMK1 | 1.06715294 |
| 53 | MAP3K3 | 1.03618018 |
| 54 | PKN2 | 1.03204726 |
| 55 | CDK18 | 1.02338302 |
| 56 | GRK6 | 1.02010393 |
| 57 | DYRK1B | 1.01341926 |
| 58 | PAK3 | 1.00373310 |
| 59 | CDK15 | 0.99970971 |
| 60 | MAPK12 | 0.99833007 |
| 61 | CAMK2A | 0.99540543 |
| 62 | CDK14 | 0.98114901 |
| 63 | CAMK1 | 0.92978371 |
| 64 | TAOK2 | 0.92584686 |
| 65 | TAOK1 | 0.92336954 |
| 66 | PTK2B | 0.90645379 |
| 67 | PRKCH | 0.88778373 |
| 68 | CAMK2B | 0.88714947 |
| 69 | CDK11A | 0.87901670 |
| 70 | CAMKK2 | 0.86036910 |
| 71 | MARK2 | 0.85988503 |
| 72 | RAF1 | 0.82807356 |
| 73 | EPHA3 | 0.82806758 |
| 74 | DYRK1A | 0.81447363 |
| 75 | RET | 0.79752240 |
| 76 | STK11 | 0.79616018 |
| 77 | CSNK1G2 | 0.76237892 |
| 78 | PTK6 | 0.74610253 |
| 79 | BLK | 0.72694015 |
| 80 | ALK | 0.70992970 |
| 81 | SGK494 | 0.67072491 |
| 82 | SGK223 | 0.67072491 |
| 83 | PRKG2 | 0.64862116 |
| 84 | IRAK2 | 0.64834024 |
| 85 | CSK | 0.64627308 |
| 86 | LMTK2 | 0.64551821 |
| 87 | ZAP70 | 0.64097518 |
| 88 | PTK2 | 0.62129413 |
| 89 | PRKCZ | 0.61105889 |
| 90 | MAP2K6 | 0.60414710 |
| 91 | SGK1 | 0.60178783 |
| 92 | HCK | 0.58931238 |
| 93 | FER | 0.58684264 |
| 94 | FGR | 0.58005621 |
| 95 | TYK2 | 0.54875497 |
| 96 | NME1 | 0.53966750 |
| 97 | MAP3K1 | 0.52537519 |
| 98 | OXSR1 | 0.52532698 |
| 99 | JAK2 | 0.52192162 |
| 100 | PRKD1 | 0.50896880 |
| 101 | BMPR2 | 0.50852485 |
| 102 | CAMK1G | 0.50265376 |
| 103 | MAP3K7 | 0.50219605 |
| 104 | PRKCE | 0.49945915 |
| 105 | DYRK2 | 0.49193531 |
| 106 | PDGFRA | 0.48981651 |
| 107 | CAMK2D | 0.48666112 |
| 108 | PDK1 | 0.48447876 |
| 109 | PDPK1 | 0.48399650 |
| 110 | FYN | 0.47938922 |
| 111 | TTN | 0.47739010 |
| 112 | ERBB3 | 0.45909371 |
| 113 | ICK | 0.45906880 |
| 114 | BRAF | 0.45610763 |
| 115 | CDC42BPA | 0.45500088 |
| 116 | MAP4K1 | 0.45430385 |
| 117 | PINK1 | 0.45382477 |
| 118 | RPS6KA3 | 0.44756653 |
| 119 | BCR | 0.44393805 |
| 120 | MAP2K1 | 0.42141390 |
| 121 | CAMK2G | 0.40661520 |
| 122 | DDR2 | 0.40453822 |
| 123 | RIPK1 | 0.40198310 |
| 124 | SIK3 | 0.40069962 |
| 125 | PKN1 | 0.38553113 |
| 126 | RPS6KA2 | 0.38502354 |
| 127 | DAPK3 | 0.38126774 |
| 128 | MAPK10 | 0.37737485 |
| 129 | CAMK4 | 0.37726567 |
| 130 | SGK2 | 0.36711508 |
| 131 | SGK3 | 0.35295197 |
| 132 | WNK3 | 0.34934184 |
| 133 | SCYL2 | 0.33054901 |
| 134 | ROCK2 | 0.31838333 |
| 135 | MAP3K6 | 0.31785398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73000631 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.26743337 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.74968638 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.68731861 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.68291631 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.65165626 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62166601 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.61767657 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45356807 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.43013956 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.31467454 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19230122 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.09655807 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.06139676 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.97681948 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.89179170 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84378067 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.71705147 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68435520 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.67924524 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.67908517 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67736128 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65798520 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65364191 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.59407200 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.57196423 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54803214 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48045332 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.40856197 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38631883 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.37521775 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35964512 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23943585 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23810773 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21141193 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20692443 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.19838090 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19590392 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18641857 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15844047 |
| 41 | Melanogenesis_Homo sapiens_hsa04916 | 1.12185402 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07037013 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04471469 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02099371 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01662047 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01476030 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.01428814 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00962241 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99424548 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99247859 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98705147 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98312097 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97267003 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93832122 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91795542 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89322653 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.88666430 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87984559 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87963616 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.85978646 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85287184 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84744903 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81453384 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77324227 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76431610 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76198351 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75703423 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74993863 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.73421473 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72443209 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72358568 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.71763661 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71685751 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71683360 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70987229 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70127911 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69870078 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69546977 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69258675 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69185311 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69011211 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.68535705 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67489271 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.67132777 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67112703 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66616246 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66593460 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66344871 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64501371 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63286585 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.61178475 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60947385 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58800273 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58596720 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56272967 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.56257827 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55216930 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.53678102 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53232988 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52796775 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52159840 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51559366 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.51481205 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51272007 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.51047720 |
| 106 | Alcoholism_Homo sapiens_hsa05034 | 0.50852508 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49950293 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49140118 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47563663 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.47462032 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46973717 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44305379 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43189076 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43003002 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40153676 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38035208 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37804012 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36662676 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35709473 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35231059 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33718986 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32272572 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31685496 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31299801 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31158738 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30907526 |
| 127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26993218 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26208965 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25165586 |
| 130 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.23037186 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22052874 |

